"The Report
Partnerships, Licensing, Investments and M&A Deals and Trends for
March 2016 in Pharmaceuticals provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz
GlobalData's
Partnerships,
Licensing, Investments and M&A Deals and Trends for March 2016 in
Pharmaceuticals report
is an essential source of data and trend analysis on partnerships,
licensing, mergers and acquisitions (M&As) and financings in the
pharmaceuticals industry. The report provides detailed information on
partnership and licensing transactions, M&As, equity/debt
offerings, private equity, and venture financing registered in the
pharmaceuticals industry in March 2016. The report portrays detailed
comparative data on the number of deals and their value in the last
six months, subdivided by deal types, various therapy areas, and
geographies. Additionally, the report provides information on the top
financial advisory firms in the pharmaceuticals industry.
Data
presented in this report is derived from GlobalDatas proprietary
in-house Pharmaceuticals eTrack deals database and primary and
secondary research.
Scope
-
Analysis of the market trends for the pharmaceutical industry in the
global arena.
-
Review of deal trends in the cardiovascular, central nervous system,
dermatology, ear nose throat disorders, gastrointestinal, genito
urinary system and sex hormones, hematological disorders, hormonal
disorders, immunology, infectious disease, male health, metabolic
disorders, mouth and dental disorders, musculoskeletal, oncology,
ophthalmology, respiratory, toxicology, and women's health segments.
-
Analysis of partnerships, licensing, M&As, equity/debt offerings,
private equity, and venture financing deals in the pharmaceutical
industry.
-
Analysis of therapy areas which are very active in terms of venture
capital financing, partnerships, licensing agreements, equity/debt
offerings, and M&As.
-
Analysis of deals based on different payment modes, including upfront
and milestone payments, primarily in partnerships and licensing
agreements in the pharmaceutical industry.
-
Analysis of partnership and licensing deals based on clinical stage
of development of products.
-
Summary of the pharmaceutical deals globally in the six months.
-
Information on the top deals happened in the pharmaceutical industry.
-
Geographies covered include - North America, Europe, Asia Pacific,
South & Central America, and the Middle East & Africa.
-
League tables of financial advisors in M&As and equity/debt
offerings. This includes key advisors such as Morgan Stanley, Credit
Suisse, and Goldman Sachs.
Reasons to buy
--
Enhance your decision making capability in a more rapid and time
sensitive manner.
-
Find out the major deal performing segments for investments in your
industry.
-
Evaluate the types of companies which are entering into partnership
or licensing agreements; divesting and acquiring assets.
-
Identify companies that are aggressively looking to raise capital in
the market
-
Evaluate niche therapy areas that are receiving majority of the
upfront and milestone payments in the pharmaceutical industry.
-
Identify the key venture capitalists, who are financing the
pharmaceutical and biotech companies.
-
Evaluate the clinical development stages where majority of the
partnerships and licensing agreements are happening.
-
Do deals with an understanding of how competitors are financed, and
the mergers and partnerships that have shaped the pharmaceutical
industry.
-
Identify growth segments and opportunities in each region within the
industry.
-
Look for key financial advisors where you are planning to raise
capital from the market or for acquisitions within the industry.
Browse More PressRelease:
Table
of Contents
1
Table of Contents 2
1.1
List of Tables 6
1.2
List of Figures 9
2
Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1
Pharmaceuticals & Healthcare, Global, Deal Analysis, March 2016
12
2.2
Pharmaceuticals & Healthcare, Global, Major Deals, March 2016 14
2.2.1
Sanofi Prices Public Offering of Notes For USD2 Billion 14
2.2.2
Perrigo Raises USD1.2 Billion in Public Offering of Notes 14
2.2.3
Shanghai Shyndec Pharma to Acquire Stakes in 12 Pharma Companies for
USD1.2 Billion 15
2.2.4
AmerisourceBergen Raises USD1.17 Billion in Private Placement of
Shares up on Exercise of Warrants 15
2.2.5
Royalty Pharma Acquires Royalty Rights of Xtandi from University of
California, Los Angeles for USD1.14 Billion 15
2.3
Pharmaceuticals & Healthcare, Global, by Type, Number of Deals,
March 2016 17
2.4
Pharmaceuticals & Healthcare, Global, by Type, Deal Values, March
2016 18
3
Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 19
3.1
Pharmaceuticals & Healthcare, Global, M&A, March 2016 19
3.1.1
Top M&A Deals in March 2016 20
3.1.2
Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy
Area, October 2015 - March 2016 21
3.2
Pharmaceuticals & Healthcare, Global, Equity Offering Deals,
March 2016 22
3.2.1
Top Equity Offering Deals in March 2016 23
3.2.2
Pharmaceuticals & Healthcare, Global, Equity Offering Deals by
Therapy Area, October 2015 - March 2016 24
3.3
Pharmaceuticals & Healthcare, Global, Private Equity and Venture
Capital Deals, March 2016 25
3.3.1
Top PE/VC Deals in March 2016 26
3.3.2
Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area,
March 2016 27
3.3.3
Pharmaceuticals & Healthcare, Global, Venture Capital Deals by
Stage of Financing, March 2016 28
3.3.4
Pharmaceuticals & Healthcare, Global, Top Venture Financing
Firms, October 2015-March 2016 30
3.3.5
Pharmaceuticals & Healthcare, Global, Top VC Backed Companies,
October 2015-March 2016 31
4
Pharmaceuticals & Healthcare, Global, Partnership Deals, March
2016 32
4.1
Pharmaceuticals & Healthcare, Global, Partnership Deals, March
2016 32
4.2
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Therapy Area, October 2015 - March 2016 34
4.3
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Upfront and Milestone Payments and Deal Values (US$ m), March 2016 35
4.3.1
Pharmaceuticals & Healthcare, Global, Top Partnership Deals by
Payment Mode, March 2016 36
4.4
Pharmaceuticals & Healthcare, Global, Partnership Deals by
Therapy Area, by Upfront and Milestone Payments and Deal Values (US$
m), October 2015 - March 2016 37
4.5
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
Number Of Deals, October 2015 - March 2016 39
4.6
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
Deal Values (US$ m), October 2015 - March 2016 40
4.7
Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase,
by Upfront & Milestone Payments and Deal Values (US$ m), October
2015 - March 2016 42
5
Pharmaceuticals & Healthcare, Global, Licensing Agreements, March
2016 44
5.1
Pharmaceuticals & Healthcare, Global, Licensing Agreements, March
2016 44
5.2
Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals,
Upfront and Milestone Payments and Deal Values (US$ m), March 2016 46
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment